Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed. This update reflects an adjustment to the version log within the study's history page.SummaryDifference0.1%

- Check17 days agoChange DetectedThe sponsor decided to rollover the remaining participants to study PHA022121-C307. The trial was terminated and results were posted, with corresponding updates to Study Status and Outcome Measures.SummaryDifference0.5%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change is limited to metadata and does not modify substantive content or functionality.SummaryDifference0.1%

- Check39 days agoChange DetectedThe latest version shows the submission was returned on 2026-07-28 and is under Quality Control Review, with the study history updated to include key sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study/Recruitment Status.SummaryDifference0.9%

- Check46 days agoChange DetectedThe study record history adds a new revision tag v3.6.4 and removes the previous v3.6.3, reflecting a newer update to the record.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study history now shows a new version (v3.6.3) with Results Submitted, indicating that results for the trial have been submitted. The previous No Results Posted state and revision v3.6.2 are superseded by this update.SummaryDifference0.1%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.